Archives

by in
Entry Author Date Location
Former Dendreon CEO Gold Working on New Cancer Drug Startups 10/13/14 Wisconsin
Arrowhead Shares Tumble on Early Phase 2a Data For RNAi Drug 10/09/14 Wisconsin
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme 01/13/14 Boston
San Diego Life Sciences Roundup: Ex-CEO Shoots Two, OncoSec, & More 09/20/13 San Diego
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Alnylam Shares Boom on Early Data For Subcutaneous RNA Drug 07/11/13 Boston
Alnylam’s Amyloidosis Drug Holds up in Second Clinical Trial 07/01/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering 01/15/13 Boston
Alnylam Inks $29M Deal With Monsanto for New Bio Tools for Farmers 08/28/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Alnylam and Glaxo Partner on RNAi for Vaccine Production 11/01/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline 09/26/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi 07/27/11 Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence 05/26/11 Boston
Alnylam Inks Deal with Precision NanoSystems 04/19/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News 03/25/11 Boston
Alnylam Named in Complaint Over RNAi Patents 03/23/11 Boston
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles 03/18/11 Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News 03/18/11 Boston
Page 1 of 4 next page »